Age-Related Morbidity and Mortality among Patients with COVID-19

키워드

참고문헌 (68)

1. "Coronavirus disease (COVID-2019) situation report -110"[URL]
2. Cesari M, "COVID-19 in Italy : ageism and decision making in a pandemic", J Am Med Dir Assoc, 21, pp.576~577 (2020)
3. "Global covid-19 case fatality rates"[URL]
4. Kim DH, "Understanding and interpretation of case fatality rate of coronavirus disease 2019", J Korean Med Sci, 35, pp.e137~ (2020)
5. "Status of COVID-19 in Korea"[URL]
6. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020", China CDC Weekly, 2, pp.113~122 (2020)
7. "Epidemia COVID-19"[URL]
8. "Coronavirus-data"[URL]
9. "Deaths registered weekly in England and Wales, provisional: week ending 8 May 2020"[URL]
10. Taubenberger JK, "1918 Influenza : the mother of all pandemics", Emerg Infect Dis, 12, pp.15~22 (2006)
11. Greer AL, "Age, influenza pandemics and disease dynamics", Epidemiol Infect, 138, pp.1542~1549 (2010)
12. Bouvier NM, "The future of influenza vaccines: a historical and clinical perspective", Vaccines (Basel), 6, pp.58~ (2018)
13. Oliva J, "Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016", Influenza Other Respi Viruses, 12, pp.161~170 (2018)
14. von der Beck D, "Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data", PLoS One, 12, pp.e0180920~ (2017)
15. "Cause-of-death statistics in 2018"[URL]
16. Promislow DEL, "A geroscience perspective on COVID-19 mortality", J Gerontol A Biol Sci Med Sci (2020)
17. "COVID-19 cases and case fatality rate by age. Knowledge for policy" (2020)[URL]
18. Koo Bo Kyung, "Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening", Infection and Chemotherapy, 52(2), pp.219~221 (2020), 대한감염학회[DOI]
19. Leung C, "Risk factors for predicting mortality in elderly patients with COVID-19 : a review of clinical data in China", Mech Ageing Dev, 188, pp.111255~ (2020)
20. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
21. Hu X, "Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19", Sci Total Environ, 728, pp.138812~ (2020)
22. Leung C, "Clinical features of deaths in the novel coronavirus epidemic in China", Rev Med Virol, 30, pp.e2103~ (2020)
23. Yu P, "Age-related rhesus macaque models of COVID-19", Animal Model Exp Med, 3, pp.93~97 (2020)
24. Castle SC, "Clinical relevance of age-related immune dysfunction", Clin Infect Dis, 31, pp.578~585 (2000)
25. Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention", Nat Rev Immunol, 20, pp.363~374 (2020)
26. Bonafè M, "Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes", Cytokine Growth Factor Rev (2020)
27. Kadkhoda K, "COVID-19 : an immunopathological view", MSphere, 5, pp.e00344~20 (2020)
28. Fu Y, "Understanding SARS-CoV-2-mediated inflammatory responses : from mechanisms to potential therapeutic tools", Virol Sin, pp.1~6 (2020)
29. Tilocca B, "Molecular basis of COVID-19 relationships in different species : a one health perspective", Microbes Infect, 22, pp.218~220 (2020)
30. Negro F, "Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?", Swiss Med Wkly, 150, pp.w20249~ (2020)
31. Takada A, "Antibody-dependent enhancement of viral infection : molecular mechanisms and in vivo implications", Rev Med Virol, 13, pp.387~398 (2003)
32. Gorse GJ, "Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum", Clin Vaccine Immunol, 17, pp.1875~1880 (2010)
33. Prill MM, "Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls", Pediatr Infect Dis J, 31, pp.235~240 (2012)
34. Liu K, "Clinical features of COVID-19 in elderly patients : a comparison with young and middle-aged patients", J Infect, 80, pp.e14~e18 (2020)
35. 김탁, "Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in Korea", Infection and Chemotherapy, 52(2), pp.133~141 (2020), 대한감염학회[DOI]
36. "Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"[URL]
37. COVID-19 National Incident Room Surveillance Team, "COVID-19, Australia: epidemiology report 6 (Reporting week ending 19:00 AEDT 7 March 2020)", Commun Dis Intell, pp.44~ (2020)
38. Dong Y, "Epidemiology of COVID-19 among children in China", Pediatrics, 145, pp.e20200702~ (2020)
39. Kam KQ, "A well infant with coronavirus disease 2019 (COVID-19) with high viral load", Clin Infect Dis (2020)
40. Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China", JAMA, 323, pp.1313~1314 (2020)
41. Zhang ZJ, "Novel coronavirus infection in newborn babies zzzzzz28 days in China", Eur Respir J, 55, pp.2000697~ (2020)
42. Monto AS, "Acute respiratory illness in an American community. The Tecumseh study", JAMA, 227, pp.164~169 (1974)
43. Stockman LJ, "Severe acute respiratory syndrome in children", Pediatr Infect Dis J, 26, pp.68~74 (2007)
44. Leung CW, "Severe acute respiratory syndrome among children", Pediatrics, 113, pp.e535~e543 (2004)
45. Bartenfeld M, "Middle East respiratory syndrome coronavirus and children", Clin Pediatr(Phila), 56, pp.187~189 (2017)
46. Thabet F, "Middle East respiratory syndrome coronavirus in children", Saudi Med J, 36, pp.484~486 (2015)
47. Memish ZA, "Middle East respiratory syndrome coronavirus disease in children", Pediatr Infect Dis J, 33, pp.904~906 (2014)
48. Cristiani L, "Will children reveal their secret? The coronavirus dilemma", Eur Respir J, 55, pp.2000749~ (2020)
49. Zimmermann P, "Coronavirus infections in children including COVID-19 : an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children", Pediatr Infect Dis J, 39, pp.355~368 (2020)
50. Lee PI, "Are children less susceptible to COVID-19?", J Microbiol Immunol Infect, 53, pp.371~372 (2020)
51. Bi Q, "Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study", Lancet Infect Dis (2020)
52. Ferrario CM, "Counterregulatory actions of angiotensin-(1-7)", Hypertension, 30, pp.535~541 (1997)
53. Tikellis C, "Angiotensin-converting enzyme 2(ACE2)Is a key modulator of the renin angiotensin system in health and disease", Int J Pept, 2012, pp.256294~ (2012)
54. Glowacka I, "Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63", J Virol, 84, pp.1198~1205 (2010)
55. de Wit E, "SARS and MERS : recent insights into emerging coronaviruses", Nat Rev Microbiol, 14, pp.523~534 (2016)
56. Imai Y, "Angiotensin-converting enzyme 2 protects from severe acute lung failure", Nature, 436, pp.112~116 (2005)
57. Vaduganathan M, "Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19", N Engl J Med, 382, pp.1653~1659 (2020)
58. Xie X, "Age-and gender-related difference of ACE2 expression in rat lung", Life Sci, 78, pp.2166~2171 (2006)
59. Sodhi CP, "Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin", BKB1R axis and facilitates LPS-induced neutrophil infiltration, 2018, pp.314, L17~L31
60. Nikolich-Zugich J, "SARS-CoV-2 and COVID-19 in older adults : what we may expect regarding pathogenesis, immune responses, and outcomes", Geroscience, 42, pp.505~514 (2020)
61. Cao Q, "SARS-CoV-2 infection in children : transmission dynamics and clinical characteristics", J Formos Med Assoc, 119, pp.670~673 (2020)
62. Mitroulis I, "Modulation of myelopoiesis progenitors is an integral component of trained immunity", Cell, 172, pp.147~161.e12 (2018)
63. Tosato F, "Lymphocytes subsets reference values in childhood", Cytometry A, 87, pp.81~85 (2015)
64. "Multisystem inflammatory syndrome in children and adolescents with COVID-19"[URL]
65. DeBiasi RL, "Severe COVID-19 in children and young adults in the Washington, DC metropolitan region", J Pediatr (2020)
66. Riphagen S, "Hyperinflammatory shock in children during COVID-19 pandemic", Lancet, 395, pp.1607~1608 (2020)
67. Jones VG, "COVID-19 and Kawasaki disease : novel virus and novel case", Hosp Pediatr, 10, pp.537~540 (2020)
68. Kim YJ, "Defining association between COVID-19 and the multisystem inflammatory syndrome in children through the pandemic", J Korean Med Sci, 35, pp.e204~ (2020)

관련 논문AI추천